Novartis announce EU approval of Odmonzo (formerly LDE225)
Novartis announce European Commission approval of Odomzo (formerly LDE225) for treatment of adults with locally invasive BCCs. For further information visit the following link. gorlingroup.org/jupgrade/in...
Start a Community